SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001390478-22-000006
Filing Date
2022-03-31
Accepted
2022-03-31 16:01:39
Documents
92
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sls-20211231.htm   iXBRL 10-K 2135564
2 EX-10.36 sls20211231ex1036nextgen.htm EX-10.36 53794
3 EX-21.1 sls20211231ex211nextgen.htm EX-21.1 4849
4 EX-23.1 sls20211231ex231nextgen.htm EX-23.1 2553
5 EX-31.1 sls20211231ex311nextgen.htm EX-31.1 8435
6 EX-31.2 sls20211231ex312nextgen.htm EX-31.2 8437
7 EX-32.1 sls20211231ex321nextgen.htm EX-32.1 6694
13 sls-20211231_g1.jpg GRAPHIC 30719
14 sls-20211231_g2.jpg GRAPHIC 175909
15 sls-20211231_g3.jpg GRAPHIC 22078
16 sls-20211231_g4.jpg GRAPHIC 132459
17 sls-20211231_g5.jpg GRAPHIC 71733
  Complete submission text file 0001390478-22-000006.txt   9206257

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sls-20211231.xsd EX-101.SCH 58716
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sls-20211231_cal.xml EX-101.CAL 79549
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sls-20211231_def.xml EX-101.DEF 197886
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sls-20211231_lab.xml EX-101.LAB 657351
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sls-20211231_pre.xml EX-101.PRE 425713
86 EXTRACTED XBRL INSTANCE DOCUMENT sls-20211231_htm.xml XML 1136712
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33958 | Film No.: 22792269
SIC: 2834 Pharmaceutical Preparations